• 800 343 7475ir@bio-techne.com bio-techne.com

    • Overview
    • News / Events
    • Company Information
    • Strategy
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    Navigation

      News / Events

    • Overview
    • News / Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Profile
      • Presentations
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
      • Annual Reports
    • Stock Data
      • Overview
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • 10-K Filings
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents

    Press Releases

    • News / Events

    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    Feb 5, 2018

    Bio-Techne To Present At The Leerink Partners 7th Annual Global Healthcare Conference

    Jan 30, 2018

    Bio-Techne's Ella™ Added to BioAgilytix Portfolio of Industry-Leading Immunoassay Platforms

    Jan 18, 2018

    Bio-Techne To Host Conference Call On February 6, 2018 To Announce Second Quarter 2018 Financial Results

    Jan 15, 2018

    Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne

    Jan 2, 2018

    Bio-Techne Acquires Atlanta Biologicals Inc.

    Dec 28, 2017

    Bio-Techne To Present At The 36th Annual J.P. Morgan Healthcare Conference

    Nov 28, 2017

    Bio-Techne's RNAscope® Technology Enabling Robust Gene Expression and Biomarker Analysis Advances Wide-ranging Research with over 1000 Publications

    Nov 20, 2017

    Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design

    Nov 14, 2017

    Bio-Techne Awards 40,000 USD Research Grant to Innovative Cancer Researcher

    Oct 31, 2017

    Bio-Techne Declares Dividend

    RSS
    • 1...
    • 37
    • 38
    • 39
    • 40
    • 41
    • 42
    • 43
    • 44
    • 45
    • 46
    • ...49
    • Email Alerts
    • Contacts
    • RSS News Feed
    Bio-Techne

    614 McKinley Place NE
    Minneapolis, MN 55413
    USA

    TEL 612 379 2956
    Toll-free 800 343 7475
    FAX 612 656 4400

    Who We Are

    • About Bio-Techne
    • Bio-Techne Brands
    • Careers
    • Corporate & Social Responsibility
    • Terms and Conditions

    Investor Relations

    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance

    Stay Connected

    • Facebook Twitter LinkedIn YouTube Instagram
    • Contact Us

    Utility Footer Menu

    • Privacy and Cookie Policy
    • Site Map
    • © Copyright 2025 Bio-Techne. All Rights Reserved.